These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 19826039)
1. Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer. Xu L; Duda DG; di Tomaso E; Ancukiewicz M; Chung DC; Lauwers GY; Samuel R; Shellito P; Czito BG; Lin PC; Poleski M; Bentley R; Clark JW; Willett CG; Jain RK Cancer Res; 2009 Oct; 69(20):7905-10. PubMed ID: 19826039 [TBL] [Abstract][Full Text] [Related]
2. [Impact of preoperative drug therapy on the expression of angiogenesis markers in colorectal liver metastases]. Varlamov AV; Pal'tseva EM; Sekacheva MI; Skipenko OG; Fedorov DN Arkh Patol; 2017; 79(1):36-42. PubMed ID: 28295006 [TBL] [Abstract][Full Text] [Related]
3. Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy. Saigusa S; Toiyama Y; Tanaka K; Yokoe T; Okugawa Y; Kawamoto A; Yasuda H; Inoue Y; Miki C; Kusunoki M Ann Surg Oncol; 2010 Aug; 17(8):2051-8. PubMed ID: 20177796 [TBL] [Abstract][Full Text] [Related]
4. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma. Kawakami T; Tokunaga T; Hatanaka H; Kijima H; Yamazaki H; Abe Y; Osamura Y; Inoue H; Ueyama Y; Nakamura M Cancer; 2002 Nov; 95(10):2196-201. PubMed ID: 12412174 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas. Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848 [TBL] [Abstract][Full Text] [Related]
6. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Willett CG; Boucher Y; di Tomaso E; Duda DG; Munn LL; Tong RT; Chung DC; Sahani DV; Kalva SP; Kozin SV; Mino M; Cohen KS; Scadden DT; Hartford AC; Fischman AJ; Clark JW; Ryan DP; Zhu AX; Blaszkowsky LS; Chen HX; Shellito PC; Lauwers GY; Jain RK Nat Med; 2004 Feb; 10(2):145-7. PubMed ID: 14745444 [TBL] [Abstract][Full Text] [Related]
7. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis. Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells. Qiao N; Wang L; Wang T; Li H Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277 [TBL] [Abstract][Full Text] [Related]
9. Leukemia regression by vascular disruption and antiangiogenic therapy. Madlambayan GJ; Meacham AM; Hosaka K; Mir S; Jorgensen M; Scott EW; Siemann DW; Cogle CR Blood; 2010 Sep; 116(9):1539-47. PubMed ID: 20472832 [TBL] [Abstract][Full Text] [Related]
10. Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness. Saidi A; Hagedorn M; Allain N; Verpelli C; Sala C; Bello L; Bikfalvi A; Javerzat S Int J Cancer; 2009 Sep; 125(5):1054-64. PubMed ID: 19431143 [TBL] [Abstract][Full Text] [Related]
11. Study of angiogenic signaling pathways in hemangioblastoma. Pierscianek D; Wolf S; Keyvani K; El Hindy N; Stein KP; Sandalcioglu IE; Sure U; Mueller O; Zhu Y Neuropathology; 2017 Feb; 37(1):3-11. PubMed ID: 27388534 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts. Roland CL; Dineen SP; Lynn KD; Sullivan LA; Dellinger MT; Sadegh L; Sullivan JP; Shames DS; Brekken RA Mol Cancer Ther; 2009 Jul; 8(7):1761-71. PubMed ID: 19567820 [TBL] [Abstract][Full Text] [Related]
13. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. Plotkin SR; Stemmer-Rachamimov AO; Barker FG; Halpin C; Padera TP; Tyrrell A; Sorensen AG; Jain RK; di Tomaso E N Engl J Med; 2009 Jul; 361(4):358-67. PubMed ID: 19587327 [TBL] [Abstract][Full Text] [Related]
14. Targeting CXCR4-dependent immunosuppressive Ly6C Jung K; Heishi T; Incio J; Huang Y; Beech EY; Pinter M; Ho WW; Kawaguchi K; Rahbari NN; Chung E; Kim JK; Clark JW; Willett CG; Yun SH; Luster AD; Padera TP; Jain RK; Fukumura D Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10455-10460. PubMed ID: 28900008 [TBL] [Abstract][Full Text] [Related]
15. Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study. Schuster C; Akslen LA; Straume O PLoS One; 2016; 11(5):e0155242. PubMed ID: 27166673 [TBL] [Abstract][Full Text] [Related]
16. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study. Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752 [TBL] [Abstract][Full Text] [Related]
18. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease. Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589 [TBL] [Abstract][Full Text] [Related]
19. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages. Wang D; Wang X; Si M; Yang J; Sun S; Wu H; Cui S; Qu X; Yu X Cancer Lett; 2020 Apr; 474():36-52. PubMed ID: 31931030 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy. Hsu JY; Wakelee HA BioDrugs; 2009; 23(5):289-304. PubMed ID: 19754219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]